T-DM1, Lapatinib, Nab-paclitaxel in HER2+ Breast Cancer

Press/Media: Press / Media

PeriodJan 7 2020

Media coverage

1

Media coverage

  • TitleT-DM1, Lapatinib, Nab-paclitaxel in HER2+ Breast Cancer
    Media name/outletBreast Cancer Research
    CountryUnited States
    Date1/7/20
    PersonsVirginia G Kaklamani